Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Br J Dermatol. 2019 Sep 22;182(5):1262–1268. doi: 10.1111/bjd.18411

Table 1.

Summary of the Australian Melanoma Family Study (development dataset) and Leeds Melanoma Case-Control Study (external validation dataset)

Study Study design Geographical location Cases/ Controls Case ascertainment Control ascertainment Diagnosis age Diagnosis years Data collection
Australian Melanoma Family Study Population-based case-control-family study Brisbane, Sydney and Melbourne, Australia 461/329 State cancer registries Electoral rolla and spouses or friends of cases 18–39 years 2000–2002 Skin examinations by dermatology trainees, and self-administered and telephone-administered questionnaires
Leeds Melanoma Case-Control Study Population-based case-control study Yorkshire, United Kingdom 960/513 Clinicians, pathology registers and cancer registries General practiceb 18–76 years 2000–2005 Skin examinations by research nurses, and self-administered and telephone-administered questionnaires
a

Population-based controls were identified from the electoral roll and frequency-matched to cases by geographical location, age and sex; and spouse/friend controls were nominated by the cases.

b

Controls were identified from the cases’ general practice patient lists and were frequency-matched to cases by age and sex